(Q39580319)

13 September 2017

title

Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis (English)

1 reference

13 September 2017

1 reference

1 reference

3

1 reference

13 September 2017

Alexander R Moschen

1

0 references

Ralf Bartenschlager

object named as

Ralf Bartenschlager

10

0 references

Elizabeth Powell

object named as

Elizabeth E Powell

7

0 references

Charles A. Dinarello

9

object named as

Charles A Dinarello

1 reference

13 September 2017

Teresa Fritz

2

1 reference

13 September 2017

Ilka Rebhan

4

1 reference

13 September 2017

Oliver Bauhofer

5

1 reference

13 September 2017

Helen D Barrie

6

1 reference

13 September 2017

Soo-Hyun Kim

8

1 reference

13 September 2017

Julie R Jonsson

11

1 reference

13 September 2017

Herbert Tilg

12

1 reference

13 September 2017

language of work or name

English

0 references

publication date

14 May 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

53

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

1819-1829

1 reference

Controversies in liver transplantation for hepatitis C.

13 September 2017

cites work

1 reference

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained

21 January 2018

1 reference

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

21 January 2018

1 reference

Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.

21 January 2018

1 reference

Interleukin-32: a cytokine and inducer of TNFalpha

21 January 2018

1 reference

IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism

21 January 2018

1 reference

IL-32, a proinflammatory cytokine in rheumatoid arthritis

21 January 2018

1 reference

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

21 January 2018

1 reference

IL-32-dependent effects of IL-1beta on endothelial cell functions

21 January 2018

1 reference

Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model

21 January 2018

1 reference

Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism

21 January 2018

1 reference

Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection

21 January 2018

1 reference

Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication.

21 January 2018

1 reference

Endogenous IL-32 controls cytokine and HIV-1 production

21 January 2018

1 reference

IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages

21 January 2018

1 reference

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

21 January 2018

1 reference

Adiponectin and its receptors in patients with chronic hepatitis C.

21 January 2018

1 reference

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

21 January 2018

1 reference

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

21 January 2018

1 reference

Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs

21 January 2018

1 reference

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta

21 January 2018

1 reference

Interleukin-32 induces the differentiation of monocytes into macrophage-like cells

21 January 2018

1 reference

Involvement of IL-32 in activation-induced cell death in T cells

21 January 2018

1 reference

Interleukin-1 Inhibits Hepatitis C Virus Subgenomic RNA Replication by Activation of Extracellular Regulated Kinase Pathway

21 January 2018

1 reference

Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein

21 January 2018

1 reference

Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection

21 January 2018

1 reference

IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis

21 January 2018

1 reference

Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.24285

1 reference

13 September 2017

1 reference